Rohto Pharmaceutical Co., Ltd. Announces Consolidated Earnings Results for the First Quarter Ended June 30, 2021
August 18, 2021 at 02:00 pm IST
Share
Rohto Pharmaceutical Co. Ltd. announced consolidated earnings results for the first quarter ended June 30, 2021. For the quarter, the company reported net sales were JPY 42,315 million compared to JPY 38,641 million a year ago. Operating income was JPY 6,008 million compared to JPY 3,575 million a year ago. Profit attributable to owners of parent was JPY 4,731 compared to JPY 1,747 million a year ago. Basic net income per share was JPY 41.48 as compared to JPY 15.32 per share a year ago. Diluted net income per share was JPY 41.36 as compared to JPY 15.27 per share a year ago.
ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.